These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19373874)

  • 21. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.
    Möller I; Thomas A; Geyer H; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2115-23. PubMed ID: 21710591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Möller I; Schäfer M; Rodchenkov G; Yin S; Loo JA; Geyer H; Schänzer W
    Eur J Mass Spectrom (Chichester); 2010; 16(3):301-12. PubMed ID: 20530837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of anabolic steroids and their relevance to drug detection in horseracing.
    Teale P; Houghton E
    Bioanalysis; 2010 Jun; 2(6):1085-107. PubMed ID: 21083210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of carbon isotope ratio mass spectrometry to doping control.
    Cawley AT; Flenker U
    J Mass Spectrom; 2008 Jul; 43(7):854-64. PubMed ID: 18523972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.
    Thevis M; Loo JA; Loo RR; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(3):297-304. PubMed ID: 17200979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometric identification of peptide hormones in doping-control analysis.
    Thevis M; Schänzer W
    Analyst; 2007 Apr; 132(4):287-91. PubMed ID: 17554406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis.
    Thevis M; Kohler M; Schlörer N; Fusshöller G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):153-61. PubMed ID: 18708695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
    Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f.
    Möller T; Wen HC; Naumann N; Krug O; Thevis M
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Walpurgis K; Geyer H; Schänzer W
    Drug Test Anal; 2016 Jan; 8(1):7-29. PubMed ID: 26767774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.
    Thevis M; Geyer H; Thomas A; Schänzer W
    Drug Test Anal; 2011 May; 3(5):331-6. PubMed ID: 21538997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.